The anti-inflammatory actions of IL-4 in human monocytes are not mediated by IL-10, RP105 or the kinase activity of RIPK2

► IL-4 down-regulates mRNA levels of LPS-induced inflammatory cytokines and chemokines. ► IL-4 causes an early up-regulation of IL-10, RIPK2, RP105 and c-Maf mRNA. ► IL-4 suppresses LPS-induced TNFα production independently of IL-4-induced IL-10. ► The anti-inflammatory actions of IL-4 are independe...

Full description

Saved in:
Bibliographic Details
Published inCytokine (Philadelphia, Pa.) Vol. 58; no. 3; pp. 415 - 423
Main Authors Woodward, Eleanor A., Kolesnik, Tatiana B., Nicholson, Sandra E., Prêle, Cecilia M., Hart, Prue H.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► IL-4 down-regulates mRNA levels of LPS-induced inflammatory cytokines and chemokines. ► IL-4 causes an early up-regulation of IL-10, RIPK2, RP105 and c-Maf mRNA. ► IL-4 suppresses LPS-induced TNFα production independently of IL-4-induced IL-10. ► The anti-inflammatory actions of IL-4 are independent of the kinase activity of RIPK2. ► IL-4 fails to up-regulate cell surface expression of the RP105 receptor in monocytes. The anti-inflammatory actions of IL-4 in activated human monocytes may reflect transcriptional regulation of genes involved in TLR signaling pathways. Tailored gene arrays were conducted to profile the expression of 84 genes central to TLR-mediated signal transduction in human monocytes treated with the TLR4 ligand, LPS, with or without IL-4. In the first 3h, IL-4 down-regulated mRNA levels of LPS-induced inflammatory cytokines and chemokines, without altering mRNA levels of TLRs, TLR-related signaling molecules or multiple transcription factors. The down-regulation of inflammatory genes by IL-4 was preceded by an early up-regulation of IL-10 mRNA and protein and mRNA for receptor-interacting serine–threonine kinase 2 (RIPK2), the TLR homolog, RP105, and c-Maf, a transcription factor required for IL-10 gene expression. However, IL-4 still suppressed LPS-induced TNFα production in bone-marrow derived macrophages from IL10−/− mice, and in the presence of a neutralizing antibody to IL-10 in human monocytes. The up-regulation of RIPK2 and RP105 mRNA by IL-4 occurred independently of IL-10. IL-4 maintained the ability to suppress LPS-induced TNFα and enhance IL-10 production in the presence of RIPK2 kinase inhibitors. Further, IL-4 failed to up-regulate expression of RP105 at the cell surface. In conclusion, the anti-inflammatory actions of IL-4 occur independently of IL-10, RP105, and the kinase activity of RIPK2.
Bibliography:http://dx.doi.org/10.1016/j.cyto.2012.03.009
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1043-4666
1096-0023
DOI:10.1016/j.cyto.2012.03.009